Levoreact Oftalmico (Levocabastine Hydrochloride)

Levocabastine acts as a selective H1 receptor antagonist. By binding to histamine H1 receptors on conjunctival cells and sensory nerves, it blocks histamine‑induced itching and inflammatory responses, providing rapid relief of allergic eye symptoms.

The dosing regimen for Levoreact Oftalmico is determined by the prescribing clinician based on the severity of the allergic condition and patient response. The prescriber will specify the number of drops and frequency of administration.

Safety data for levocabastine hydrochloride in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals.

To request Levoreact Oftalmico, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levoreact contains levocabastine, a selective H1 antagonist known for rapid onset of action and minimal systemic absorption. Compared with non‑selective antihistamines, it often offers quicker symptom relief and a lower incidence of systemic side effects, though individual response may vary.

Levoreact should be stored at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain sterility.

Levoreact is applied topically to the eye. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. Avoid touching the tip of the bottle to the eye or any surface.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, persistent ocular pain, and significant visual disturbances. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to levocabastine hydrochloride or any excipients in the formulation should avoid using Levoreact. Additionally, patients with active ocular infections, severe inflammation, or uncontrolled glaucoma should consult a specialist before use.